Trends in Benzisothiazolinone Sensitization: A Retrospective Analysis From 2010 to 2022, in a Tertiary Belgian Hospital
Contact Dermatitis · 2026-01 · 94 (1) · 40-45
DOI: 10.1111/cod.70017 ↗At a glance
Journal article in Contact Dermatitis, published online on 2025-09-17. Written by Anne Herman and 2 co-authors. Institution: Department of Dermatology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain (UCLouvain), Brussels, Belgium. Major MEDLINE topics: Dermatitis, Allergic Contact, Thiazoles, Dermatitis, Occupational, Preservatives, Pharmaceutical. Cited 2 times so far (Crossref); 16 references.
Abstract (original language)
Background
Benzisothiazolinone is a preservative responsible for allergic contact dermatitis, with occupational exposure being a common source of sensitisation.
Objectives
To investigate the prevalence of positive patch test reactions to benzisothiazolinone (BIT) in Belgium, between January 2010 and December 2022, and to assess co‐sensitisations to other isothiazolinone derivatives in sensitised patients.
Methods
A retrospective monocentric study of patch test results with benzisothiazolinone (BIT) 0.1% petrolatum observed in patients attending a Belgian tertiary hospital. Prevalence, demographic data, concomitant patch test reactions, and clinical relevance were analysed.
Results
Overall, 65 of 6128 patients (1.06%) had a positive patch test reaction to benzisothiazolinone, and its sensitisation rate increased from 0.39% in 2010 to 3.72% in 2019 (followed by a decline to 0.71% in 2022). Occupational exposure was relevant in 20% of cases, with painters and metalworkers being the most affected professions. Unexpectedly, 10.8% of BIT‐sensitised patients underwent patch testing due to complications following orthopaedic prosthesis implantation.
Conclusions
This study confirms a significant rise in BIT sensitisation over time, followed by a recent unexplained decline. Occupational exposure remains a major risk factor, but other environmental sources, including consumer products, such as leather products, should not be overlooked. The BIT sensitisation in orthopaedic prosthesis‐related complications requires further investigation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Dermatology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.
- Institute of Experimental and Clinical Research, Pneumology, LUNS Pole, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.
- Statistical Support Unit, King Albert II Cancer and Hematology Institute, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
ORCID profiles: Anne Herman, Marie Baeck
Cite
APA
Herman, A., Sawadogo, K., & Baeck, M. (2026). Trends in Benzisothiazolinone Sensitization: A Retrospective Analysis From 2010 to 2022, in a Tertiary Belgian Hospital. Contact Dermatitis, 94(1), 40-45. https://doi.org/10.1111/cod.70017
Vancouver
Herman A, Sawadogo K, Baeck M. Trends in Benzisothiazolinone Sensitization: A Retrospective Analysis From 2010 to 2022, in a Tertiary Belgian Hospital. Contact Dermatitis. 2026;94(1):40-45. doi:10.1111/cod.70017
BibTeX
@article{Herman2026,
author = {Herman, Anne and Sawadogo, Kiswendsida and Baeck, Marie},
title = {Trends in Benzisothiazolinone Sensitization: A Retrospective Analysis From 2010 to 2022, in a Tertiary Belgian Hospital},
journal = {Contact Dermatitis},
year = {2026},
volume = {94},
number = {1},
pages = {40--45},
doi = {10.1111/cod.70017}
}
EUVIMED